title: Neurological problems in the adolescent population.
abstract: Adolescent patients pose a unique challenge to child neurologists. Although there are a number of neurological disorders that present in childhood and persist through adolescence, there are some disorders like juvenile myoclonic epilepsy (JME) that occur more commonly in this age group. We discuss common neurological disorders encountered by adolescent medicine physicians that have been affected by recent advances in the field of adolescent neurology. We also address the challenges of transitioning care to an adult neurologist.
authors.affiliation: Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI, USA.
authors.forename: Venu
authors.initials: V
authors.lastname: Parachuri
authors.forename: Christopher
authors.initials: C
authors.lastname: Inglese
mesh_terms: D000293:Adolescent; D000295:Adolescent Medicine / Q000458:organization & administration*; D000700:Analgesics / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D046690:Deep Brain Stimulation; D020773:Headache Disorders / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D019586:Intracranial Hypertension / Q000175:diagnosis / Q000628:therapy; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000628:therapy; D020190:Myoclonic Epilepsy, Juvenile / Q000175:diagnosis / Q000628:therapy; D009422:Nervous System Diseases / Q000175:diagnosis* / Q000628:therapy*; D059906:Neuroimaging; D058825:Serotonin 5-HT1 Receptor Agonists / Q000627:therapeutic use; D020323:Tics / Q000175:diagnosis / Q000188:drug therapy; D005879:Tourette Syndrome / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D000700:Analgesics; D000927:Anticonvulsants; D018501:Antirheumatic Agents; D058825:Serotonin 5-HT1 Receptor Agonists